17 May 2021 17 May 2021Categories Clinical trialDown syndrome: a molecule that targets cognitive impairments enters the decisive phase of clinical trialsSignificant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]